ACRS

ACLARIS THERAPEUTICS INC

ACRS·00461U105·US·Common Stock·Healthcare - Biotechnology-13D/G

ACRS (ACLARIS THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($27.8M), RA CAPITAL MANAGEMENT, L.P. ($25.5M), VANGUARD CAPITAL MANAGEMENT LLC ($19.4M). Net institutional sentiment: Mixed.

88
Holders
(10 Elite)
$200M
Total Value
55% (87)
Consensus
48 buying - 39 selling
13F: Insider & Congress:
ACRSSmart Money Verdict
View all
Held by 88 funds
10 elite
Who's Trading
ActivistVOVivo Opportunity Fund Holdings, L.P.4.3%May 12, 2026
InsiderHWHall Jesse WayneExercise 36K shMay 1, 2026
InsiderHWHall Jesse WayneTax 9K shMay 1, 2026
ActivistBIBML Investment Partners, L.P.9.9%Apr 27, 2026
InsiderLMLeonard Braden MichaelSell $1.4MApr 23, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.6.3%Apr 7, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistDTDeep Track Capital, LP7.0%Mar 17, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.2%Jan 21, 2026
ActivistBIBiosion, Inc.9.4%Jan 9, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.4M(+8.8%)$27.8M0.0%+179.49%
31
New
6.8M$25.5M0.3%+83.55%
47
New
5.2M$19.4M0.0%+83.55%
39
Increased
3.9M(+14.8%)$14.5M0.0%+118.63%
32
New
3.4M$12.6M0.0%+83.55%
39
Decreased
2.7M(-19.6%)$10.3M0.0%+232.80%
0
Increased
2.4M(+1.3%)$9.1M0.0%+31.89%
28
Increased
2.2M(+86.6%)$8.4M0.0%+130.30%
43
Increased
2M(+33.4%)$7.5M0.0%+153.89%
35
New
1.7M$6.2M0.0%+83.55%
38
Increased
1.5M(+100.2%)$5.6M0.0%+87.87%
44
Decreased
1.4M(-1.1%)$5.3M0.0%+151.45%
0
Increased
997,850(+1.1%)$3.7M0.0%+59.44%
27
Decreased
900,804(-57.0%)$3.4M0.0%+339.02%
0
Decreased
756,127(-28.2%)$2.8M0.0%+70.72%
0
Increased
728,225(+9.6%)$2.7M0.0%+52.64%
29
Increased
712,984(+46.9%)$2.7M0.0%+109.88%
36
New
628,859$2.4M0.0%+83.55%
36
Decreased
588,691(-6.9%)$2.2M0.0%+182.06%
0
Increased
511,461(+88.8%)$1.9M0.0%+81.10%
41

Showing 1-20 of 95

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used